Neuron-protective effect of subanesthestic-dosage ketamine on mice of Parkinson's disease

Conclusions The subanesthestic-dosage ketamine has some protective effects on the coordinating ability of movement and cognitive ability of Parkinson's disease mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. This is probably due to that the autophagy activity of cells is activated by subanesthestic-dosage ketamine and that the neurons are protected.
Source: Asian Pacific Journal of Tropical Medicine - Category: Tropical Medicine Source Type: research